The Clinical Characteristics of a Stage II Colorectal Cancer T4 Tumor: A Ten-Year Single-Center Research Report
Based on our data, patients diagnosed with pathologic T4aN0M0 CRC appeared to experience a trend toward better 10-year OS when compared to those with T4bN0M0 disease, but this trend lacks statistical significance. Patients with locally advanced Stage II colon cancer clearly benefited from adjuvant chemotherapy therapy; therefore, FOLFOX may not necessarily be required.
Authors
- Chun-Yu Lin (ORCID: https://orcid.org/0000-0002-8552-7244)
- Ming-Cheng Chen (ORCID: https://orcid.org/0000-0002-5158-5091)
- Chou‐Chen Chen (ORCID: https://orcid.org/0000-0003-3323-8739)
- Chang-Lin Lin (ORCID: https://orcid.org/0000-0003-0781-1511)
- Shang-Chih Huang
- Feng‐Fan Chiang (ORCID: https://orcid.org/0000-0002-5071-3370)
- Bo-Zhi Lin
Institutions
- Taichung Veterans General Hospital (TW)
Publication Details
- Journal
- Current Oncology
- Published
- 2024-12-12
- DOI
- https://doi.org/10.3390/curroncol31120584
- Citations
- 2
- Primary Topic
- Colorectal Cancer Surgical Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.57
Funders
- Taichung Veterans General Hospital